Glycemic variability can threaten your health, even when your diabetes seems to be under control. GlycoMark is an indicator of recent glycemic control that is associated with average daily peak glucose levels, not a three-month average level. Having more complete information can make diabetes management more effective. GlycoMark. It’s what you should know. Now.
Read moreMaintaining your target blood glucose level is the key to managing diabetes. It’s about the way you feel. And the way you live. GlycoMark provides information about average daily peak glucose levels that other tests don’t show. Is GlycoMark right for you? Talk to your doctor today.
Read moreGlycoMark is the only specific indicator of hyperglycemia and glycemic variability among other tests used for monitoring glucose control, such as A1C and fructosamine. It tells you more than you can learn from A1C and fasting blood glucose testing. Use GlycoMark in devising patient-personalized strategies for hitting and holding targeted blood glucose levels. Look closer, here.
Read more
The GlycoMark test is an FDA-cleared, non-fasting serum or plasma test for monitoring blood glucose variability in people with diabetes. The GlycoMark test provides quantitative measurement of 1,5-anhydroglucitol (1,5-AG) in serum or plasma. The test is for professional use, and is indicated for the intermediate term monitoring of glycemic control in people with diabetes.